News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
151
Sources here
14
Companies here
3
Search results Stored financial headlines

Active search

151 matching headlines

Ticker or company: NVUMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Kenvue Inc. $KVUE Shares Bought by Bank of America Corp DE

Bank of America Corp DE increased its stake in Kenvue Inc. (NYSE:KVUE) by 9.5% in the first quarter, acquiring an additional 1.23 million shares, bringing its total to 14.18 million shares valued at approximately $244.5 million. Kenvue exceeded Q1 earnings expectations with adjusted EPS …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quantinno Capital Management LP Acquires 502,024 Shares of Kenvue Inc. $KVUE

Quantinno Capital Management LP increased its stake in Kenvue Inc. by 59.5% in the first quarter, acquiring an additional 502,024 shares, bringing their total ownership to 1.35 million shares valued at approximately $23.2 million. Institutional investors now own 97.64% of Kenvue, while analysts maintain …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Avidity Partners Management LP Sells 132,800 Shares of Kenvue Inc. $KVUE

Avidity Partners Management LP significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by selling 132,800 shares in the first quarter, although the firm still retains 100,000 shares valued at $1.72 million. Kenvue reported strong first-quarter earnings, beating analyst expectations with $0.32 EPS and $3.91 …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue's Q2 Earnings Coming Up: Here's What Lies Ahead of the Stock

Kenvue Inc. KVUE is slated to report second-quarter 2026 results on Aug. 6, before market open. The company is likely to report top and bottom-line increase when it posts the quarterly results. For revenues, the consensus mark is pegged at $4 billion, implying a …

KVUE main company KVUE main company
Sharemaestro market context Trend signal active 52 weeks -17.9% · Next-week setup negative 16.5% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

California State Teachers Retirement System Has $54.20 Million Stock Holdings in Kenvue Inc. $KVUE

The California State Teachers Retirement System reduced its stake in Kenvue Inc. by 2% in the first quarter, selling 65,394 shares but still holding over 3.14 million shares valued at $54.2 million. Kenvue reported strong Q1 earnings and revenue, exceeding analyst estimates, and maintained …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amundi Sells 2,791,015 Shares of Kenvue Inc. $KVUE

Amundi reduced its stake in Kenvue Inc. (NYSE:KVUE) by 17.6% in the first quarter, selling over 2.79 million shares. Despite this sell-off, other institutional investors like EverSource Wealth Advisors and Royal Bank of Canada increased their holdings in Kenvue. The company recently reported strong …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What Are Wall Street Analysts' Target Price for Kenvue Stock?

Kenvue Inc. (KVUE), the world's largest pure-play consumer health company, has seen its stock decline 11.7% over the past year but rebound 14.5% year-to-date in 2026. This resurgence follows concerns over sluggish sales, competition, and talc litigation, with current optimism stemming from the company's …

KVUE main company KVUE main company
Sharemaestro market context Trend signal active 52 weeks -17.9% · Next-week setup negative 16.5% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue (KVUE) Projected to Announce Quarterly Earnings on Thursday

Kenvue (KVUE) is projected to release its Q2 2026 earnings before market open on Thursday, August 6th, with analysts anticipating $0.3188 EPS and $3.9660 billion in revenue. The company previously exceeded estimates in Q1 2026, reporting $0.32 EPS against a $0.27 consensus. Kenvue's stock …

KVUE main company KVUE main company
Sharemaestro market context Trend signal active 52 weeks -17.9% · Next-week setup negative 16.5% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FEED|ENvue Medical Ord Shs|Price:0.330|Chg%:-0.013

This article provides real-time quotes, trading strategies, and related analysis for ENvue Medical Ord Shs (FEED). It includes current key figures, price performance over various periods, technical indicators, and major shareholder information. The company's stock price currently stands at 0.330 USD, showing a 3.73% …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue Number of Employees 2026 | Employee Count & Headcount Data

Kenvue, Inc. (KVUE) had approximately 21,995 total employees worldwide as of March 2026, marking a 31.8% growth since 2023 but a 1.3% decline year-over-year in 2026. The company is actively hiring, with 958 active job postings in 2026, and its workforce is concentrated in …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue Inc. (NYSE:KVUE) to Issue Quarterly Dividend of $0.21

Kenvue Inc. (NYSE:KVUE) has declared a quarterly dividend of $0.21 per share, representing an annualized yield of approximately 4.2%. The dividend is payable on August 26th to shareholders of record by August 12th, with an ex-dividend date also on August 12th. The company's dividend …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue's Brand Strength and Growth Drivers Shape Its Future Outlook

Kenvue Inc. KVUE remains a closely watched consumer health name as investors weigh trusted brands, improving margins and a major pending transaction. The company's mix of self-care, beauty and everyday health products gives it a broad demand base, but uneven organic growth and execution …

KVUE main company KVUE main company
Sharemaestro market context Trend signal active 52 weeks -17.9% · Next-week setup negative 16.5% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue Increases Quarterly Dividend to $0.21 from $0.2075 a Share; Payable Aug. 26 to Holders of Record Aug. 12

Kenvue Inc. has announced an increase in its quarterly dividend to $0.21 per share, up from the previous $0.2075. This dividend is scheduled to be paid on August 26 to shareholders of record as of August 12. The company is a global leader in …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue Benefits From Consumer Health Trends and Margin Expansion

Investors evaluating Kenvue Inc. KVUE must balance better execution with uneven growth. The company has trusted consumer health brands, recovering beauty trends and improving profitability, but demand is not accelerating evenly across categories. Deal uncertainty adds another layer. The pending Kimberly-Clark Corporation KMB transaction …

KVUE main company KVUE main company
Sharemaestro market context Trend signal active 52 weeks -17.9% · Next-week setup negative 16.5% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue raises quarterly dividend by 1.2% to $0.21 per share

Kenvue Inc. announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock, an increase of 1.2% from the previous dividend. This dividend is payable on August 26, 2026, to shareholders of record as of August 12, …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue Increases Quarterly Cash Dividend

SUMMIT, N.J., July 29, 2026--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock, which represents a 1.2 percent increase compared to the prior quarterly dividend. The quarterly dividend is …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -17.9% · Next-week setup negative 16.5% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Readystate Asset Management LP Grows Position in Kenvue Inc. $KVUE

Readystate Asset Management LP significantly increased its stake in Kenvue Inc. (NYSE:KVUE) by 76.8% in the first quarter, now owning over 1 million shares valued at $18.2 million. Other institutional investors have also adjusted their positions in Kenvue, with hedge funds and institutional investors …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ENvue Medical develops robotic feeding tube placement system

ENvue Medical Inc. has launched ENvue Drive, a robotic-assisted system designed for the automatic and safer placement of feeding tubes. This system, built on ENvue's FDA-cleared electromagnetic navigation platform, integrates AI and real-time guidance to improve accuracy and reduce misplacements which currently affect 3-5% …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue Inc (KVUE) Financial Health: Profitability & Balance Sheet Analysis

Kenvue Inc (KVUE) has a stable financial score of 7.35, ranking 18th in the Personal & Household Products & Services industry. The company reported a 4.49% year-over-year increase in revenue to $3.91 billion and a significant 47.20% rise in net profit for its latest …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue Inc. stock rises Monday, outperforms market

Kenvue Inc. (KVUE) shares increased by 1.04% to $19.48 on Monday, outperforming the broader market. Both the S&P 500 Index and the Dow Jones Industrial Average also saw gains. This marks the second consecutive day of increases for Kenvue's stock.

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

First Trust Advisors LP Has $49.81 Million Holdings in Kenvue Inc. $KVUE

First Trust Advisors LP significantly reduced its stake in Kenvue Inc. by 13.6% in the first quarter, now holding 2,888,992 shares valued at $49.81 million. Despite this reduction, institutional investors collectively own 97.64% of Kenvue's stock. The article also details recent insider stock sales, …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue Inc. $KVUE Shares Acquired by Gabelli Funds LLC

Gabelli Funds LLC significantly increased its stake in Kenvue Inc. by 71.2% in Q1, acquiring 301,350 additional shares, bringing their total holding to 724,635 shares valued at $12.5 million. Kenvue (KVUE) reported strong quarterly earnings of $0.32 EPS, beating estimates, and a 4.5% year-over-year …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Absolute Gestao de Investimentos Ltda. Takes Position in Kenvue Inc. $KVUE

Absolute Gestao de Investimentos Ltda. has acquired a new position in Kenvue Inc. (NYSE:KVUE), purchasing 923,260 shares valued at approximately $15.92 million, making it their 16th largest holding. Other institutional investors have also adjusted their stakes, with some increasing their holdings significantly. Kenvue's stock …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tylenol With Naproxen FDA Approval Could Be A Game Changer For Kenvue (KVUE)

Kenvue recently received FDA approval for Tylenol with Naproxen, a new over-the-counter pain reliever offering up to 12 hours of pain relief and slated for distribution across major U.S. retailers. This product launch adds a differentiated option to Kenvue's Self Care portfolio, potentially strengthening …

KVUE main company KVUE main company
Sharemaestro market context Trend signal active 52 weeks -17.9% · Next-week setup negative 16.5% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Kenvue (KVUE) Stock A Bargain With Lawsuits Back In Focus?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Kenvue stock has delivered a decline of 11.7% over the past year, yet the current Discounted Cash Flow (DCF) intrinsic value estimate indicates …

KVUE main company KVUE main company
Sharemaestro market context Trend signal active 52 weeks -17.9% · Next-week setup negative 16.5% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue (KVUE) Gets An FDA Lift On Tylenol As Valuation Looks Tight

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The FDA's approval of Tylenol with Naproxen, a new over the counter pain reliever offering up to 12 hours of relief, has put Kenvue …

KVUE main company KVUE main company
Sharemaestro market context Trend signal active 52 weeks -17.9% · Next-week setup negative 16.5% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

5,211,114 Shares in Kenvue Inc. $KVUE Acquired by Kryger Capital LLC

Kryger Capital LLC has acquired a significant new stake in Kenvue Inc. (NYSE:KVUE), purchasing over 5.2 million shares valued at approximately $89.84 million, making it their sixth-largest holding. Other institutional investors like Healthcare of Ontario Pension Plan Trust Fund and Renaissance Technologies LLC also …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form DEF 14A ENvue Medical Inc For: 24 July By Investing.com

This article announces the filing of Form DEF 14A by ENvue Medical Inc. for July 24. It appears to be a standard financial news announcement from Investing.com, providing basic information about a regulatory filing. The content itself is very brief and focuses solely on …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GABELLI & Co INVESTMENT ADVISERS INC. Raises Holdings in Kenvue Inc. $KVUE

GABELLI & Co INVESTMENT ADVISERS INC. increased its stake in Kenvue Inc. (NYSE:KVUE) by 77.3% in the first quarter, now owning 742,600 shares valued at $12.8 million. Other institutional investors also modified their holdings, while Kenvue recently declared a quarterly dividend of $0.2075 per …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue, Inc. Revenue Breakdown – FWB:J4D

Kenvue, Inc. (FWB:J4D) generated €12.88 billion in revenue last year, with its Self Care segment being the top performer, contributing €5.43 billion. The United States was the company's largest regional contributor, accounting for €5.50 billion in the same period. The report provides a financial …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

FDA Clears Kenvue's TYLENOL With Naproxen, First OTC Fixed-Dose Combination

(RTTNews) - Kenvue Inc. (KVUE) announced that the FDA has approved TYLENOL with Naproxen, the first and only over the counter fixed dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) for pain relief. This new formulation combines the fast-acting relief of …

KVUE main company KVUE main company
Sharemaestro market context Trend signal active 52 weeks -17.9% · Next-week setup negative 16.5% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Envue Medical announces special shareholder meeting

Envue Medical will hold a virtual special shareholder meeting on August 14, 2026, to vote on a proposed reverse stock split, with a ratio between 1-for-2 to 1-for-50. Shareholders will also consider adjourning the meeting if more time is needed to solicit votes. This …

FEED main company
Sharemaestro market context Price below Trend Line 52 weeks -91.9% · Next-week setup negative 31.4% FEED stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kenvue Inc (KVUE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Kenvue Inc (KVUE) by business segment and geographical region. As of April 6, the company generated $2.87 billion from Face and Body Care and $2.42 billion from Other Self Care, with Northern America contributing the highest …

KVUE main company
Sharemaestro market context Trend signal active 52 weeks -7.9% KVUE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context